Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C. De Vivo, Wildon Farwell, Wuh‐Liang Hwu et al.|Neuromuscular Disorders|2019Cited by 636
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the<scp>NURTURE</scp>studyThomas O. Crawford, Kathryn J. Swoboda, Darryl C. De Vivo et al.|Muscle & Nerve|2023Cited by 117